Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 575

1.

High HIV testing and low HIV prevalence among injecting drug users attending the Sydney Medically Supervised Injecting Centre.

Salmon AM, van Beek I, Amin J, Grulich A, Maher L.

Aust N Z J Public Health. 2009 Jun;33(3):280-3. doi: 10.1111/j.1753-6405.2009.00389.x.

PMID:
19630850
2.

Five years on: what are the community perceptions of drug-related public amenity following the establishment of the Sydney Medically Supervised Injecting Centre?

Salmon AM, Thein HH, Kimber J, Kaldor JM, Maher L.

Int J Drug Policy. 2007 Jan;18(1):46-53. Epub 2007 Jan 8.

PMID:
17689343
3.

Injecting-related injury and disease among clients of a supervised injecting facility.

Salmon AM, Dwyer R, Jauncey M, van Beek I, Topp L, Maher L.

Drug Alcohol Depend. 2009 Apr 1;101(1-2):132-6. doi: 10.1016/j.drugalcdep.2008.12.002. Epub 2009 Jan 23.

PMID:
19167171
4.

Young adult injection drug users in the United States continue to practice HIV risk behaviors.

Rondinelli AJ, Ouellet LJ, Strathdee SA, Latka MH, Hudson SM, Hagan H, Garfein RS.

Drug Alcohol Depend. 2009 Sep 1;104(1-2):167-74. doi: 10.1016/j.drugalcdep.2009.05.013. Epub 2009 Jun 25.

PMID:
19559543
5.

Determinants of HIV risk among men who have homosexual sex and inject drugs.

Crofts N, Marcus L, Meade J, Sattler G, Wallace J, Sharp R.

AIDS Care. 1995;7(5):647-55.

PMID:
8652699
6.

Differences across sexual orientation on HIV risk behaviours in injecting drug users.

Ross MW, Wodak A, Gold J, Miller ME.

AIDS Care. 1992;4(2):139-48.

PMID:
1606209
7.
8.

Factors associated with an explosive HIV epidemic among injecting drug users in Sargodha, Pakistan.

Emmanuel F, Archibald C, Razaque A, Sandstrom P.

J Acquir Immune Defic Syndr. 2009 May 1;51(1):85-90. doi: 10.1097/QAI.0b013e31819906f3.

PMID:
19289969
9.

Changes in HIV prevalence and risk among new injecting drug users in a Russian city of high HIV prevalence.

Platt L, Rhodes T, Hickman M, Mikhailova L, Lisetsky K, Sarang A, Lewis K, Parry J.

J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):623-31. doi: 10.1097/QAI.0b013e318165dbf7.

PMID:
18209680
10.

Developing surveillance for HIV transmission and risk behaviours among high-risk groups in a central London health district.

Nardone A, Mercey D, Johnson AM, McCarthy M.

J Public Health Med. 1999 Jun;21(2):208-14.

PMID:
10432252
11.
12.

Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.

Vicknasingam B, Narayanan S, Navaratnam V.

Drug Alcohol Rev. 2009 Jul;28(4):447-54. doi: 10.1111/j.1465-3362.2009.00087.x.

PMID:
19594801
13.

HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: implications for intervention.

Talu A, Rajaleid K, Abel-Ollo K, Rüütel K, Rahu M, Rhodes T, Platt L, Bobrova N, Uusküla A.

Int J Drug Policy. 2010 Jan;21(1):56-63. doi: 10.1016/j.drugpo.2009.02.007. Epub 2009 Apr 22.

PMID:
19395249
14.

Prevalence, incidence and risk factors for hepatitis C in homosexual men: data from two cohorts of HIV-negative and HIV-positive men in Sydney, Australia.

Jin F, Prestage GP, Matthews G, Zablotska I, Rawstorne P, Kippax SC, Kaldor JM, Grulich AE.

Sex Transm Infect. 2010 Feb;86(1):25-8. doi: 10.1136/sti.2009.038182. Epub 2009 Oct 19.

PMID:
19841001
15.

High hepatitis C incidence in new injecting drug users: a policy failure?

Maher L, Li J, Jalaludin B, Chant KG, Kaldor JM.

Aust N Z J Public Health. 2007 Feb;31(1):30-5.

PMID:
17333606
16.

Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study.

Rhodes T, Platt L, Maximova S, Koshkina E, Latishevskaya N, Hickman M, Renton A, Bobrova N, McDonald T, Parry JV.

Addiction. 2006 Feb;101(2):252-66.

PMID:
16445554
17.

Measuring risk of HIV and HCV among injecting drug users in the Russian Federation.

Platt L, Sutton AJ, Vickerman P, Koshkina E, Maximova S, Latishevskaya N, Hickman M, Bonell C, Parry J, Rhodes T.

Eur J Public Health. 2009 Aug;19(4):428-33. doi: 10.1093/eurpub/ckp041. Epub 2009 Apr 5.

PMID:
19349288
18.

HIV infection in injecting drug users attending centres in England and Wales, 1990-1991.

Noone A, Durante AJ, Brady AR, Majid F, Swan AV, Parry JV, Hart GJ, Connell JA, Perry KR, Joce RE, et al.

AIDS. 1993 Nov;7(11):1501-7.

PMID:
8280418
19.

Condom use among injection drug users accessing a supervised injecting facility.

Marshall BD, Wood E, Zhang R, Tyndall MW, Montaner JS, Kerr T.

Sex Transm Infect. 2009 Apr;85(2):121-6. doi: 10.1136/sti.2008.032524. Epub 2008 Sep 23.

PMID:
18812391
20.

Young and recent-onset injecting drug users are at higher risk for HIV.

Fennema JS, Van Ameijden EJ, Van Den Hoek A, Coutinho RA.

Addiction. 1997 Nov;92(11):1457-65.

PMID:
9519489

Supplemental Content

Support Center